SOLA Biosciences Japan Receives AMED Grant to Advance SOL-257, Innovative Gene Therapy Aiming to Restore TDP-43 Function for ALS Patients
TOKYO and BOSTON, Sept. 28, 2026 /PRNewswire/ -- SOLA Biosciences Japan GK ("SOLA Japan"), the wholly owned Japanese subsidiary of Boston-based SOLA Biosciences Inc. (together, "SOLA"), announced that it has been awarded a grant of approximately 6...
Lifespan Vision Ventures Leads Violet Therapeutics' $4.75M Seed Extension Financing
NORWALK, Conn., May 19, 2026 /PRNewswire/ -- Lifespan Vision Ventures (LVV), an investment firm focused on therapeutics that improve human healthspan, today announced that it has led Violet Therapeutics' $4.75 million seed extension financing, with...
Eureka Robotics Raises USD 10.5 Million Series A to Accelerate Deployment of Physical AI for Precision Manufacturing and Logistics
Advances the development and deployment of flagship products Eureka Controller and Eureka 3D Camera Scales operations in Singapore and Japan, and enables full entry in the US market SINGAPORE, Dec. 12, 2024 /PRNewswire/ -- Singapore-based start-up...